Gangnam Severance Hospital Begins Its DYNAPEX PLATFORM Subscription

Gangnam Severance Hospital has begun its DYNAPEX PLATFORM subscription. On April 30, 2026, Gangnam Severance Hospital adopted DYNAPEX PLATFORM to use brain imaging AI analysis solutions within a unified platform environment.

The subscription includes DYNAPEX’s key product lineup — DYNAPEX BT, DYNAPEX METS, DYNAPEX AD, and DYNAPEX PD — together with partner plug-in products CERCARE NEUROSUITE and NEUROPHET AQUA. This enables clinical teams to use multiple brain imaging AI analysis solutions within the DYNAPEX PLATFORM environment.

DYNAPEX will continue expanding platform subscription cases at leading medical institutions while strengthening its product and partner ecosystem for integrated, precision brain imaging AI workflows.